NPR's Ari Shapiro talks with Dr. Jeff Bahr, who oversees medical group operations at Advocate Aurora Health Care in Wisconsin, about challenges the U.S. may face in the COVID-19 vaccine distribution.
A portion of the first coronavirus vaccines have been designated to go to Indian Country, but some tribes are skeptical about the federal government's ability to deliver and distribute the vaccines.
Dr. Jeff Bahr with the Advocate Aurora Health system in Wisconsin says his hospitals are "ready to go" for vaccinations. Staff who treat COVID-19 patients will be first in line, he says.
The FDA will likely make a decision about approving Pfizer's vaccine "shortly after" an advisory committee meeting on Thursday. The agency has found "no specific safety concerns" about the vaccine.
The rule would require health officials to review about 2,400 regulations on everything from Medicare benefits to prescription drugs approvals. Those not analyzed within two years would become void.
The federal government has released detailed local data on where hospitals are starting to fill up with patients. Researchers and health leaders say this was urgently needed.
A majority of hospital nurses said they had never been tested for the coronavirus, according to a recent survey. Hospitals say they are simply following the CDC's guidance.
Dr. Francis Collins, director of the National Institutes of Health, says people in some of the highest-risk groups will likely be starting vaccinations this month.
The actors and their supporters say that the union is dropping nearly 12,000 people — many over the age of 65 — from its health care plan at the height of the coronavirus pandemic.
NPR's Michel Martin speaks with Paul Black, CEO of Winston Medical Center in Louisville, Miss., about the challenges the hospital faces with the influx of COVID-19 patients.
This week’s Medical Minute, discusses “Remote Ischemic Conditioning”, a relatively simple technique that scientist hope will become a useful treatment for Hemorrhagic strokes, the most deadly type of stroke.
A new antiviral drug, MK-4482/EIDD-2801 or Molnupiravir, completely suppresses SARS-CoV-2 transmission in some animals within 24 hours, researchers in the Institute for Biomedical Sciences at Georgia State University have discovered.
Jerome Adams acknowledged earlier missteps but says he's confident in plans for vaccine distribution. And after the Thanksgiving spike in cases, he says "targeted closures and mandates" may be needed.
The U.S. government says it will issue a vaccine card and use other tools to help millions of Americans follow through with their immunizations against COVID-19.
